Literature DB >> 2543571

Endothelin binding sites in porcine aortic and rat lung membranes.

S M Kanse1, M A Ghatei, S R Bloom.   

Abstract

High-affinity binding sites for endothelin were identified on porcine aortic and rat lung membranes. Interaction of 125I-labelled endothelin with its binding site was specific, saturable, time- and temperature-dependent but dissociation of receptor-bound ligand was minimal. Maximal binding was observed at pH 7.0 in porcine aorta and at pH 3.1 in the rat lung. Treatment of membranes with trypsin destroyed the binding site in both tissues. Porcine endothelin showed a higher affinity for receptors in both tissues compared to rat endothelin. Vasoactive peptides and Ca2+ channel antagonists did not interact with this site suggesting high specificity of binding. Analysis of saturation binding showed that the number of binding sites was 1250 +/- 104 and 1650 +/- 170 fmol/mg protein and the affinity of binding sites was 0.47 +/- 0.15 and 0.16 +/- 0.07 nM in the aorta and the lungs respectively (n = 5). Presence of protease inhibitors did not alter binding suggesting that the label was stable under the incubation conditions. This was further confirmed by HPLC. Removal of the endothelium from the aorta did not change the binding characteristics of this tissue. Ca2+ and Mg2+ ions caused an increase in binding by increasing the affinity. Binding was completely abolished in the presence of Triton and dithiothreitol. The binding sites identified in this study may be responsible for the actions of endothelin in the aorta and the lung.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543571     DOI: 10.1111/j.1432-1033.1989.tb14814.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Elevated plasma endothelin in patients with diabetes mellitus.

Authors:  K Takahashi; M A Ghatei; H C Lam; D J O'Halloran; S R Bloom
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus.

Authors:  C Advenier; B Sarria; E Naline; L Puybasset; V Lagente
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

3.  Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

Authors:  C Serradeil-Le Gal; C Jouneaux; A Sanchez-Bueno; D Raufaste; B Roche; A M Préaux; J P Maffrand; P H Cobbold; J Hanoune; S Lotersztajn
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

4.  Localisation of endothelin like immunoreactivity in adult and developing human gut.

Authors:  C Escrig; A E Bishop; H Inagaki; G Moscoso; K Takahashi; I M Varndell; M A Ghatei; S R Bloom; J M Polak
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

5.  Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea.

Authors:  D W Hay; W C Hubbard; B J Undem
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.

Authors:  K Lawson; M Barras; E Zazzi-Sudriez; D J Martin; J M Armstrong; P E Hicks
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

Review 7.  Nitric oxide and endothelin in pathophysiological settings.

Authors:  T E Hunley; S Iwasaki; T Homma; V Kon
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.